Fig. 7 | Oncogene

Fig. 7

From: Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells

Fig. 7

CBX increases the survival of treated mice in a xenogenic human AML model. a Experimental procedure of in vivo experiments with OCI-AML-3 human AML model (at least three for each condition). b (Left) CBX treatment improved the mice survival. b (Right) AML induced major splenomegaly in the untreated group, which was not observed in treated mice

Back to article page